-
Fintech Focus Roundup For February 20, 2020
Saturday, February 20, 2021 - 7:21am | 1565Fintech Spotlight: How Morpher Lets You Buy Apple, On A Weekend, With As Little As $1 When typically discussed, blockchain lacks a utility component. That’s what Morpher CEO Martin Fröhler is looking to change. Fröhler is a mathematician, with a background in quantitative finance,...
-
Cannabis Movers & Shakers: TILT, MindMed, EnWave, Zelira
Friday, February 19, 2021 - 9:21am | 747TILT Hires Two Compliance Experts TILT Holdings Inc. (CSE: TILT) (OTCQX: TLLTF) strengthened its leadership team by welcoming Nicole Moyers as vice president of compliance and Patrick Beyea as director of compliance. Moyers has extensive experience in government affairs, public service...
-
MindMed To Buy AI Medicine Company HealthMode For CA$42M
Thursday, February 18, 2021 - 12:39pm | 487MindMed (NEO: MMED) (OTCQB: MMEDF) agreed to buy HealthMode, an artificial intelligence medicine company, in a CA$41.56 million (US$32.5 million) stock and cash deal. The psychedelic biotech company confirmed Thursday it will acquire a digital medicine and therapeutics startup that relies...
-
Psyched: MindMed Enters Psychedelics 2.0, Mind Cure Raises $18M, Mydecine Raises $13M
Wednesday, February 17, 2021 - 11:44am | 829Mind Cure Closes $18M Raise Mind Cure Health Inc. (CSE:MCUR) recently announced the closing of a CA$23 Million ($18.1 million) offering. The company issued approximately 38 million units, consisting of one share and one half of a share purchase warrant, at CA$0.60 per unit. The proceeds...
-
The Horizons Psychedelic Stock Index ETF, As Told By Its Fund Manager
Thursday, February 11, 2021 - 10:33am | 1149On January 27, the Horizons Psychedelic Stock Index ETF (NEO:PSYK) became the first exchange traded fund to focus solely on the psychedelics industry. Horizons ETFs CEO Steve Hawkins sat down with Benzinga to discuss the listing, which brought in approximately CA$25 million ($19.4 million) in...
-
Psychedelics Advocate, Investor Zappy Says 2021 Is 'The Year To Invest In Plant Medicine'
Monday, February 8, 2021 - 7:21am | 925Get into psychedelics now. That's according to Michael "Zappy" Zapolin, a former Bear Stearns VP turned psychedelics advocate and filmmaker. Zappy's call to invest comes as psychedelics make a continued push towards credibility on the medical, legal and business...
-
Psyched: First Psychedelics ETF Debuts; Hawaii, Florida and Connecticut Eye Psilocybin Legalization; Psyence Goes Public
Sunday, January 31, 2021 - 12:02pm | 1263First Psychedelics ETF Debuts On NEO Exchange Psychedelics’ first exchange traded fund went public last Wednesday. The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK’, and managed by Horizons ETFs Management. PSYK is a...
-
First Psychedelics ETF Debuts On NEO Exchange
Wednesday, January 27, 2021 - 8:41am | 807The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK.’ PSYK is the first exchange traded fund providing exposure to the burgeoning industry of medicinal psychedelics. The ETF is managed by Horizons ETFs...
-
Fintech Focus For January 25, 2021
Sunday, January 24, 2021 - 11:47pm | 3113Quote To Start The Day: You can't be a real networker unless you’re connected. Source: Michael Gruen One Big Thing In Fintech: Experts say 2021 is poised to see greater adoption and venture capital investment in blockchain technology. That prediction comes as more financial services apps...
-
MindMed Begins First-Ever Clinical Trial On MDMA, LSD Combinations
Wednesday, January 20, 2021 - 9:11am | 471Mind Medicine (MindMed) Inc (OTC: MMEDF), a medicine biotech company in psychedelics, on Wednesday announced its start of the first-ever clinical trial measuring and evaluating 3,4-methylenedioxymethamphetamine (MDMA) and lysergic acid diethylamide (LSD) combinations in the human body, at the...
-
What Will The Psychedelics Space Look Like In 2021? Experts Weigh In
Monday, January 18, 2021 - 11:43am | 1182In 2020, psychedelics took the world by storm. Over two dozen companies in the sector became publicly listed. The industry grew closer to federal legalization of the first psychedelic compounds for therapeutic use. With scientific, regulatory and corporate developments becoming...
-
Psyched: Compass Launches Center Of Excellence, Entheon Purchases HaluGen, Atai Buys Majority Stake In Recognify
Saturday, January 16, 2021 - 9:38am | 999Compass Launches Center Of Excellence Compass Pathways (NASDAQ: CMPS) officially launched the Centre of Excellence, in collaboration with The Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore, Maryland. This “clinic model” will study and...
-
2020 Was The Year of Psychedelics — Here's Why
Monday, December 28, 2020 - 9:02am | 1903While many 2020 memories will be gladly left behind, that's not necessarily the case for psychedelics. There was unprecedented renaissance as psychedelic compounds, and their potential to treat mental health conditions, became one of the centerpieces of this year’s public...
-
Cannabis Countdown: Top 10 Marijuana and Psychedelics Industry News Stories Of The Week
Tuesday, December 22, 2020 - 11:00am | 1911Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of December 14th – 20th, 2020. Without further ado, let’s get started. * Yahoo Finance readers, please ...
-
Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories Of The Week
Tuesday, December 22, 2020 - 10:56am | 2391Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of December 14th – 20th, 2020. Without further ado, let’s get started. * Yahoo Finance readers, please click...